Qualifyze

Overview
News
Supply Chain Tech?
Product stageSegments
Growth
?
Third-party risk management
?

Qualifyze, founded in 2019 and based in Frankfurt, Germany, is a leading company in supply chain risk management for the Life Sciences industry. The company offers an integrated audit management platform that streamlines compliance audits for pharmaceutical and healthcare companies. Qualifyze's platform provides a centralized system to manage various aspects of audits, including GxP, ESG, and ISO, covering planning, execution, and CAPA follow-ups. By leveraging one of the world's largest databases of pre-existing audit reports and real-time supplier data, Qualifyze enables quality, procurement, and supply chain functions to assess supplier performance and conduct more accurate supplier risk profiling.

The company's services enhance operational transparency and regulatory adherence while significantly reducing the time and administrative burden typically associated with compliance processes. In 2023, Qualifyze launched its first analytics solutions, drawing on data from over 3,000 audits conducted in more than 85 countries. This positioned the company as a key partner in strategic risk management, providing insights into global compliance trends and supply chain quality. In 2024, Qualifyze introduced a proprietary Quality Compliance Rating (QCR) certificate, functioning as a scoring system to help drug manufacturers quickly identify reliable partners

Qualifyze's platform connects manufacturers, suppliers, and a global network of more than 250 auditors and quality experts for streamlined collaboration. The company has conducted over 3,000 audits across 85+ countries, building what it claims to be the largest and most accurate supplier network and data analytics tools in the sector.

Key customers and partnerships

Qualifyze has established itself as a trusted partner for over 1,200 pharmaceutical and healthcare companies globally. Its client roster includes industry leaders such as Merck, Moehs, DSM, Olon, Siegfried, Teva, CordenPharma, Cipla, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Sandoz, and Mallinckrodt Pharmaceuticals. Approximately 80% of Qualifyze's customers were based outside of Germany, with about 20% located outside of Europe, demonstrating the company's global reach and appeal in the pharmaceutical industry.

 

Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Bockenheimer Anlage 46 Frankfurt DEU
Founded year:
2019
Employees:
101-250
IPO status:
Private
Total funding:
USD 85.7 mn
Last Funding:
USD 54.0 mn (Series B; Sep 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.